A remedy for chronic fatigue syndrome (CFS) containing dehydroepiandrosterone sulfate (DHAS) or a pharmaceutically acceptable salt thereof as the active ingredient. The administration of DHAS or its salt to a patient with CFS serves to supplement the plasma DHAS decreased in the patient and recover the lowered immunocompetence, thereby remitting chronic general malaise, a feeling of exhaustion and psychoneurosis.
